JP:4547 Stock Latest News
PremiumCompany AnnouncementsKissei Pharmaceutical Revamps Executive Compensation System Kissei Pharmaceutical Co. Increases Year-End Dividend Amid Growth Strategy Kissei Pharmaceutical Unveils Ambitious ‘Beyond 80’ Growth Plan PremiumCompany AnnouncementsKissei and Ferring Terminate Co-promotion Agreement for Desmopressin Products Kissei Expands Market for Tavalisse in Taiwan Through New Partnership Kissei’s YSELTY Gains European Approval for Endometriosis PremiumCompany AnnouncementsKissei Pharmaceutical Launches YSELTY in Europe Kissei Partners with Reborna for Rare Disease Therapies Kissei Pharmaceutical Expands AML Treatment Options